Ginwa Enterprise Group Inc. operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Ginwa Enterprise Group Inc. with three other
companies in this sector in China:
Shenzhen Neptunus Interlong Bio technique Co Ltd
sales of 721.35 million Chinese Renmimbi [US$107.01 million]
of which 63%
was Manufacturing & selling medicine product),
Autobio Diagnostics Co Ltd
(716.48 million Chinese Renmimbi [US$106.29 million]
Shanghai Fudan Forward S&T Co Ltd
(715.69 million Chinese Renmimbi [US$106.17 million]
of which 59%
During the year ended December of 2015, sales at
Ginwa Enterprise Group Inc. were 727.82 million Chinese Renmimbi (US$107.97 million).
increase of 2.4%
versus 2014, when the company's sales were 710.59 million Chinese Renmimbi.
This was the fifth consecutive year of sales increases at Ginwa Enterprise Group Inc.
(and since 2010, sales have increased a total of 122%).
Sales of Pharmaceutical Commerce saw an increase
that was more than double the company's growth rate: sales were up
13.4% in 2015, from
272.28 million Chinese Renmimbi to 308.83 million Chinese Renmimbi.
Not all segments of Ginwa Enterprise Group Inc. experienced an increase in sales in 2015:
sales of Pharmaceutical Industry fell 4.5% to 380.99 million Chinese Renmimbi.